Treeline | Blog
Some of the data collected by this provider is for the purposes of personalization and measuring advertising effectiveness. We do not use cookies of this type. Some of the data collected by this provider is for the purposes of personalization and measuring advertising effectiveness. We do not use cookies of this type. We do not use cookies of this type.
Treeline | Blog Mandate Method Medicines Team News Back 9.3.2025 Medicines in the making: introducing our first clinical programs By Josh Bilenker, M.D., Co-Founder and CEO, Treeline Treeline was founded with an ambitious vision – to create the next great enduring biopharma by pursuing carefully selected targets with the best available technology. That meant taking on the challenge of building an integrated team across disciplines—lab based and computational—working together, under the same roof. It also meant building a deep preclinical pipeline with flexibility to vet projects thoroughly bef
Explore this link on the map →saved by
related reading
- The pharma industry from Paul Janssen to today: why drugs got harder to develop and what we can do about it | Alex’s blogatelfo.github.io
- Going Founder Mode On Cancer - by Elliot Hershbergcenturyofbio.com
- Tech vs Biotech - Celine Haliouacelinehh.com
- Where are all the trillion dollar biotechs?ladanuzhna.xyz
- Hub-and-Spoke Biotechs: BridgeBio - by Elliot Hershbergcenturyofbio.com
- The 23andMe Deal - Cremieux Recueilcremieux.xyz
- Unmet Needs Index — Biopharma Disease Prioritizationinsights.convoke.bio
- Curious cases of financial engineering in biotechowlposting.com
- Letter | Terrainterrain.com
- A Conversation With Navvye Anand (Bindwell) | Rowanrowansci.com
- What the Aging Field Needs - Celine Haliouacelinehh.com
- Liquidity in Drug Discovery – Bharath Ramsundar – Entrepreneur and Scientistrbharath.github.io